Accelovance — Melbourne, Florida

Accelovance is a clinical research site located in Melbourne, Florida, United States 32935.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Accelovance has participated in 12 clinical trials.

Therapeutic areas: Meningitis, Meningococcal, Menopause, Plague.

Sponsors: Pfizer, TherapeuticsMD, PharmAthene UK Limited.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accelovance?

Accelovance has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accelovance conducted?

Accelovance has 12 clinical trials on record. Their work covers Meningitis, Meningococcal, Menopause, Plague.

Is Accelovance accredited by Crixeo Health?

Yes — Accelovance holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.